To investigate the effectiveness of intensive innovative methods for implementing dietary prescriptions on weight management and glycaemic control in overweight men with Type II diabetes. DESIGN: A randomised clinical trial with a 12-week intervention period F three isocaloric dietary intervention groups (intermittent energy restriction, pre-portioned meals and self-selected meals) each with weekly dietitian contact F and a followup visit after 18 months. SUBJECTS: A total of 51 men with Type II diabetes (mean age 54 y, mean body mass index (BMI) 31.7 kg/m 2 ). MEASUREMENTS: Weight, body composition, waist circumference, glycaemic control (HbA 1c ) and blood lipids. RESULTS: For all subjects, intensive diet therapy over the 12-week intervention period resulted in a mean reduction in energy intake of 236072780 kJ/day (5647665 kcal/day) and significant reductions in weight (6.474.6 kg), waist circumference (8.174.6 cm), percent body fat (1.971.5%), HbA 1c (1.071.4%) and triglyceride levels (0.370.6 mmol/l) compared to baseline levels. Intervention group did not affect clinical outcomes, with the exception of percent body fat. A total of 27 (52.9%) subjects attended the 18-month follow-up visit. At this visit, none of the improvements in clinical parameters was maintained, with all parameters returning to preintervention levels. CONCLUSIONS: A dietary prescription of 6000-7000 kJ/day (1400-1700 kcal/day) was effective in achieving a 6% weight loss and improving glycaemic control. The method of implementation made no difference to the outcomes between groups at 12 weeks or 18 months. Thus, we propose that it was the intensive weekly contact with a health professional in combination with moderate energy restriction that facilitated the successful short-term results seen.
Introduction
As many as 90% of people with Type II diabetes are overweight or obese. 1 Modest weight reductions of 5-10% have been associated with improvements in fasting plasma glucose, glycosylated haemoglobin (HbA 1c ), insulin and lipid levels, and blood pressure. 2, 3 Dietary prescriptions for weight loss and the treatment of diabetes have been well studied. A systematic review of the literature has shown that adherence to energy-and fatreduced dietary prescriptions will result in a 5-10% weight loss for at least 6 months. 4 In people with Type II diabetes, dietary prescriptions of 6700 kJ/day (1600 kcal/day) have been shown to result in mean weight losses of greater than 6 kg over 12 weeks, regardless of macronutrient mix. 5 The use of very-low-calorie diet (VLCD) prescriptions of between 1700 and 3300 kJ/day (400 and 800 kcal/day), in people with and without Type II diabetes, has shown significant improvements in weight management and glycaemic control. 1, [6] [7] [8] VLCD therapy generally produces more rapid weight loss and higher short-term success than moderate caloric restriction, yet, as with traditional dietary approaches, these losses are generally not sustained in the long term. 1, 6 A recent meta-analysis of 29 US studies examining long-term weight loss maintenance indicated that subjects who undertook an initial weight loss VLCD treatment maintained a greater percentage weight loss of initial body weight at 5 y than subjects using a hypoenergetic balanced diet, 6.2 vs 2.0%, respectively. 9 Saris 10 compared nine randomised controlled trials which used VLCD or lowcalorie diets in the treatment of obesity and found a large variation in the initial weight loss regain, ranging from 26 to 121% at a 5 y follow-up. The current Position Statement by the American Diabetes Association (ADA) for the treatment of diabetes recommends the use of structured programs that emphasise lifestyle changes including education, reduced fat and energy intake, regular physical activity and regular participant contact, for producing weight loss. 11 Few studies however have compared different methods for implementing the dietary prescription (reduced fat and energy intake). While many studies have been successful in achieving weight loss and improvements in glycaemic control in the short term, the ADA has noted that optimal strategies for achieving long-term weight loss have yet to be defined. 11 Indeed, some feel that it may not be possible. 12 The aims of this study were (1) to investigate the effectiveness of intensive innovative methods for implementing isocaloric dietary prescriptions on weight management and glycaemic control in overweight men with Type II diabetes after 12 weeks; and (2) to determine if the implementation method resulted in maintaining these improvements.
Methods

Study design
This was a randomised-controlled trial with a 12-week intervention period. Participants were subsequently followed up at 18 months. Prior to randomisation, baseline data were collected and subjects underwent 2 weeks of dietary stabilisation, which involved individualised dietary counselling on the principles of a 6000-7000 kJ/day (1400-1700 kcal/day) diet, comprising 50% of energy from carbohydrate and 30% of energy from fat.
Following the dietary stabilisation period subjects were randomised, using a random number table, into one of three dietary intervention groups for the 12-week intervention period F intermittent energy restriction (IER), pre-portioned meals (PPM) and self-selected meals (SSM). All diets were isocaloric, averaging 6000-7000 kJ/day (1400-1700 kcal/day). Subjects in each of the intervention groups visited the clinic dietitian and physician fortnightly and telephone contact with the dietitian was made on alternate weeks. Dietary intake and weight were monitored during this period. At the end of the 12-week period, all clinical outcomes were reassessed. Approximately 18 months after completion of the intervention period, subjects were contacted and invited for a follow-up visit, where clinical outcomes were measured. The follow-up was not part of the original study protocol and as such participants were not informed of the 18-month follow-up visit at the commencement of the study.
Subjects
Overweight and obese men with Type II diabetes were recruited for participation in the study by newspaper advertisements. Subjects were included in the study if they had Type II diabetes, treated with oral hypoglycaemic agents or by diet alone, were less than 70 y of age and had a body mass index (BMI) between 25 and 40 kg/m 2 . Subjects were excluded if any of the following medical conditions were present: active thyroid disease, active psychiatric disease (eg severe depression and schizophrenia), unstable angina, elevated urate levels, autonomic neuropathy, impaired renal function, or were using medications such as lithium, anticonvulsants or antipsychotic drugs.
Dietary interventions
The dietary interventions were aimed to reflect the removal of food cues (IER group), the removal of food preparation cues (PPM group) and usual dietetic intervention (SSM group). Subjects randomised to the IER group were supplied with a liquid meal replacement formula (Modifast s , Novartis Ltd, Melbourne, Australia), providing 4180 kJ/day (1000 kcal/ day), which they were required to consume for 4 consecutive days each week. On the remaining 3 days of the week, ad libitum eating similar to the dietary stabilisation phase was encouraged so that energy intake averaged 6000-7000 kJ/day (1400-1700 kcal/day) over the week. Men randomised to the PPM group had all meals and snacks provided to them on a weekly basis (Mitchell Foods, Brisbane, Australia). These meals cost $100 per week, for which subjects paid $50. Meals provided on average 6900 kJ/day (1650 kcal/day; 51% of energy from carbohydrate, 20% from protein and 29% from fat). Subjects randomised to the SSM group were advised to continue to prepare and select their own meals according to the dietary recommendations provided during the dietary stabilisation phase.
Assessments
Standardised methods were used for the collection of all measurements throughout the study. Height and weight were measured without shoes or heavy clothing to the nearest 0.1 cm and 0.1 kg, respectively. Waist circumference was measured to the nearest 0.1 cm, taken at the minimum circumference between the xiphoid process and the iliac crest. All measures were taken in duplicate and the mean used. Body composition was measured using whole body dual-emission X-ray absorptiometry (DEXA) for the chest, abdomen and pelvis regions (Hologic QDR-4500A machine). Owing to logistical difficulties with the DEXA machine, the last 13 subjects were unable to have measurements conducted at week 12. These missing data are random with no One-way analysis of variance (ANOVA) and Fisher's exact test were used to determine whether dietary groups differed at baseline and whether differences existed between those subjects who were followed up and those who were lost to follow-up. Changes in variables at each time point were compared using the repeated measures general linear model, to determine differences between diet groups. To examine changes over the three time periods for all subjects, and to maximise the amount of data that were used in the analysis, a repeated measures analysis of variance regression model, using a generalised estimating equations approach, was carried out using the SUDAAN statistical package (Version 7.5, 1997, NC, USA). The significance was set at Po0.05.
Ethical issues
The study received ethical approval from the Princess Alexandra Hospital Ethics Committee and the Queensland University of Technology Human Research Ethics Committee. All subjects received written and oral information before consenting. Informed consent was obtained separately from all subjects for the original intervention and follow-up visit.
Results
In all, 51 male subjects were eligible for the study. Baseline characteristics of subjects did not differ significantly across the three diet groups (Table 1) . A total of 27 (52.9%) subjects attended the follow-up visit 18 months after the original intervention. Subjects lost to follow-up had similar baseline characteristics and showed similar changes in outcome measures over the 12-week intervention period, to the subjects who attended the follow-up. Loss to follow-up was not different between the diet groups (P ¼ 0.94).
There was no significant difference between diet groups for changes in all clinical outcome measures after 12 weeks intervention with the exception of body composition, or for changes in clinical outcome measures at 18 months followup. Retrospective power calculations for the initial intervention period indicated that the sample size was sufficient to detect significant differences in weight and HbA 1c between Intensive diet therapy improves Type II diabetes in the short term S Ash et al diet groups with 93 and 96% power, respectively, and a Type I error of 5% (two-tailed). The sample at follow-up was sufficient to detect significant differences in weight and HbA 1c between diet groups with 97 and 95% power, respectively, and a Type I error of 5% (two-tailed). As such, results have been discussed for all subjects rather than by comparing diet groups.
Weight loss
Significant weight loss was observed at the end of the intervention period for all men (Po0.001), with subjects losing a mean of 6.474.6 kg (6.576.0% loss of initial body weight). At 18 months follow-up, the weight was not significantly different from weight at baseline (P ¼ 0.195, Table 2 ). Of the 27 subjects at 18 months follow-up, four (14.8%) were weight stable (r1 kg weight loss or gain) and 23 (85.2%) regained weight (41 kg weight gain). No subjects continued to lose weight.
Body composition A significant reduction in percent body fat after 12 weeks was observed in all subjects for whom consecutive measurements were taken (36), with subjects losing a mean of 1.971.5% body fat (Po 0.001). At the end of the 12-week intervention period, subjects in the PPM group had a significantly greater reduction in percent body fat (2.671.6%) compared to subjects in the SSM group (0.971.4%, P ¼ 0.009) but it was not significantly different from the IER group (2.071.1%, P ¼ 0.406). Percent body fat was similar to baseline levels at follow-up (P ¼ 0.83, Table 2 ). Waist circumference decreased significantly during the intervention period, with a mean reduction of 8.174.6 cm (Po0.001), but was no different from baseline measurements at 18 months follow-up (P ¼ 0.480).
Dietary intake
At completion of the intervention period, mean energy intake was similar between the diet groups (P ¼ 0.98). A significant mean reduction in energy intake of 236072780 kJ/day (5647665 kcal/day) was evident after 12 weeks of dietetic intervention compared to energy intake prior to dietary stabilisation (Po0.001, Table 3 ). At followup, subjects' energy intake had significantly increased since the completion of the intervention (Po0.001).
Glycaemic control A significant mean reduction in HbA 1c of 1.071.4% was observed after 12 weeks (Po0.001). Exploratory analyses indicated that diet groups did not differ in the proportion of subjects to reach normal glycaemia (HbA 1c o6%) . Subjects who reached normal glycaemia (13) had significantly greater weight loss at 12 weeks (9.975.0 kg) than subjects (26) where HbA 1c remained greater than 6% (5.974.1 kg, P ¼ 0.011). At 18 months follow-up, HbA 1c was similar to baseline levels (P ¼ 0.749, Table 2 ).
Lipids
Triglyceride levels significantly reduced by 0.370.6 mmol/l at the end of the intervention period (P ¼ 0.02, Table 2 ), but was not significantly different from baseline levels at 18 Intensive diet therapy improves Type II diabetes in the short term S Ash et al months follow-up. Total cholesterol and LDL cholesterol did not differ significantly from baseline either at the end of the intervention period or at 18 months follow-up. Height-density lipoprotein (HDL) cholesterol was not significantly different from baseline levels after 12 weeks but had significantly increased by 0.1570.18 mmol/l at follow-up.
Discussion
Weight loss has been the primary focus in the prevention and early management of Type II diabetes, yet current dietary strategies are ineffective in achieving long-term weight loss. 11, 16 This study used a standardised diet prescription averaging 6000-7000 kJ/day (1400-1700 kcal/day) across three intervention groups but varied the implementation to test the most effective strategy. The results indicate that the difference in the method of implementation had no effect on the amount of weight loss or reduction in HbA 1c after 12 weeks. Rather, the study demonstrated that intensive dietetic therapy for 12 weeks, involving moderate caloric restriction, individualised dietary counselling and weekly contact with a dietitian, showed positive effects on weight and glycaemic control. Our results showed a mean weight loss of 6.5% in men after the 12-week intervention. Other studies that investigated the use of intermittent energy restriction or preprepared meals (providing 60% of energy intake) over 10-12 week-periods, have shown comparable amounts of weight loss in people with Type II diabetes, ranging from 4.0 to 7.4 kg. 5, 6 In people with Type II diabetes, modest weight loss is associated with improvements in markers for diabetes. In this study, HbA 1c improved significantly over the 12-week period, independent of dietary intervention. Overall, a 6.5% reduction in weight was associated with a 1% reduction in HbA 1c . Additionally, subjects who achieved normal glycaemia (HbA 1c o6%) had a significantly greater weight loss over the 12-week period. Results of the United Kingdom Prospective Diabetes Study (UKPDS) indicated beneficial effects on diabetes complications with improved glycaemic control. 17 Epidemiological analyses of the UKPDS data have shown positive relations between glycaemic control and the risk of microvascular and macrovascular complications. A 1% reduction in HbA 1c has been associated with a 35% reduction in microvascular complications and an 18% reduction in combined fatal and nonfatal myocardial infarction. 17 Although significant improvements in weight, body composition, glycaemic control and triglyceride levels were observed over the 12-week intervention period, these improvements had not been maintained when subjects were followed up at 18 months. Improvements in HDL cholesterol at 18 months follow-up were not supported by changes in the other clinical parameters. We are therefore unable to explain why this change has occurred.
Although loss to follow-up was high, subjects studied at 18 months were comparable in every respect to the original study population. The 18-month follow-up was not part of the original study protocol, but approved as an important component later. As such, subjects were not informed of this as part of the initial intervention and therefore some subjects were unable to be contacted for the follow-up visit.
In our study, HbA 1c had returned to baseline levels at 18 months follow-up. The UKPDS has shown that regardless of the type of treatment, conventional vs intensive, HbA 1c reduced initially but then steadily increased even with continued treatment. 18 Similarly, Wing et al 8 showed that even when weight loss was maintained over 2 y, improvements in fasting blood glucose, HbA 1c and insulin levels were not maintained. Our results indicate that intensive diet therapy may delay progressive increases in HbA 1c associated with advancing disease. The regain of weight following an initial weight loss intervention is not uncommon. Many studies have shown similar results, with regaining weight at 1-5 y follow-up. 3, 7, 10 Lack of dietetic contact or ongoing intervention following the completion of the initial intervention has been shown to be less effective in producing continued weight loss or maintaining weight loss. 19, 20 This study tried to mimic real clinical practice as much as possible. The pre-prepared meals and meal replacement were subsidised or provided free to subjects for the initial intervention, as has been the case with previous studies. 5, 6, 8, 21 As such, following the initial intervention, application to long-term therapy is limited by subjects' willingness to pay. Wing et al 22 found that weight loss was greater during initial treatment and at 12 and 18 months follow-up for intervention groups where food was provided free of charge for participants, compared to groups without food provision. Similarly, Ditschuneit et al 21 provided preprepared meals over a longer 'maintenance' time period resulting in continued weight loss over 24 months. These methods however are not sustainable in real practice. Regardless, the use of preprepared meals for a short period was thought to transfer knowledge on appropriate meal size and types of foods eaten. In our study, it was not obvious that the potential retraining effect of the IER or PPM groups was sustained in outcomes in the long term. Our study provided intensive contact with a dietitian in the initial intervention, but did not compare interventions provided by other health professionals. While dietitians have the nutrition knowledge and food and counselling skills, the limited evidence regarding nutrition interventions provided by dietitians vs other health professionals is mixed. 23 Predictors of long-term success indicate the importance of intensive initial intervention with regular participant contact and structured dietary protocol to maximise energy restriction. Without regular follow-up, improvements are not maintained. 1 Our study indicates that in men with Type II diabetes moderate energy restriction in combination with frequent intensive intervention with an appropriately
Intensive diet therapy improves Type II diabetes in the short term S Ash et al trained health professional are the critical factors to achieve weight loss and improvements in clinical outcomes. We speculate that the ongoing nutritional support is equally important and that it is this component of nutrition care that is frequently underrated or ignored. 24 Further research is required to determine the frequency of follow-up that is necessary to maintain the clinical benefits associated with weight loss.
